Articles published by Propanc Biopharma, Inc.
![](https://mms.businesswire.com/media/20240625873108/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20240416646279/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20240116234298/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20231218038127/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20231213150393/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20231107592805/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230815610577/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230725421087/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230713047552/en/808594/22/propanc-logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230705534324/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230622006763/en/808594/22/propanc-logo.jpg)
Propanc Biopharma Provides Shareholder Update
June 22, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230606005114/en/808594/22/propanc-logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230525005383/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230523005567/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230522005770/en/808594/22/propanc-logo.jpg)
Propanc Biopharma Announces Reverse Stock Split
May 22, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230328005086/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230316005332/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20230111005367/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20221213005527/en/808594/22/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20221130005451/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20221115005869/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20221026005460/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20221012005513/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20220929005345/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20220913005798/en/808594/5/propanc-logo.jpg)
Propanc Biopharma Provides Shareholder Update
September 13, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220908005698/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20220823005415/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20220816005485/en/808594/5/propanc-logo.jpg)
![](https://mms.businesswire.com/media/20220803005047/en/808594/5/propanc-logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.